Skip to main content
TipRanks
Go Ultimate75% OFF

Krebs Biochemicals & Industries Ltd. (KREBSBIO) Ratios

0 Followers

Krebs Biochemicals & Industries Ltd. Ratios

IN:KREBSBIO's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:KREBSBIO's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio0.090.100.280.330.45
Quick Ratio0.030.040.120.080.12
Cash Ratio0.000.000.000.000.00
Solvency Ratio-0.03-0.06-0.04-0.07-0.14
Operating Cash Flow Ratio-0.08-0.080.04-0.50-0.22
Short-Term Operating Cash Flow Coverage-0.15-0.150.23-2.44-1.69
Net Current Asset Value₹ -3.16B₹ -3.05B₹ -2.80B₹ -2.58B₹ -2.29B
Leverage Ratios
Debt-to-Assets Ratio1.381.261.341.050.99
Debt-to-Equity Ratio-1.38-1.45-2.00-1.84-2.50
Debt-to-Capital Ratio3.623.222.002.191.66
Long-Term Debt-to-Capital Ratio205.6510.742.852.352.30
Financial Leverage Ratio-1.00-1.16-1.49-1.76-2.53
Debt Service Coverage Ratio-0.05-0.25-0.56-1.16-2.11
Interest Coverage Ratio-1.68-3.67-3.31-7.38-7.33
Debt to Market Cap2.621.451.391.510.46
Interest Debt Per Share107.52101.18112.8786.3689.74
Net Debt to EBITDA-65.63-14.81-28.83-12.08-5.73
Profitability Margins
Gross Profit Margin27.51%87.17%-21.57%46.84%-9.65%
EBIT Margin-41.49%-48.51%-29.83%-41.66%-65.56%
EBITDA Margin-14.43%-33.06%-16.41%-29.08%-55.01%
Operating Profit Margin-50.03%-50.15%-30.72%-42.08%-66.15%
Pretax Profit Margin-71.35%-62.16%-39.13%-47.36%-74.58%
Net Profit Margin-71.35%-62.20%-39.13%-47.36%-74.58%
Continuous Operations Profit Margin-71.35%-62.20%-39.13%-47.36%-74.58%
Net Income Per EBT100.00%100.06%100.00%100.00%100.00%
EBT Per EBIT142.61%123.97%127.36%112.55%112.74%
Return on Assets (ROA)-10.37%-15.94%-11.07%-14.11%-23.46%
Return on Equity (ROE)10.40%18.42%16.55%24.83%59.30%
Return on Capital Employed (ROCE)-23.66%-33.15%-13.31%-17.43%-35.34%
Return on Invested Capital (ROIC)-10.65%-18.65%-12.24%-16.13%-32.40%
Return on Tangible Assets-10.39%-16.16%-11.23%-14.33%-23.82%
Earnings Yield-19.75%-18.47%-14.19%-20.27%-14.44%
Efficiency Ratios
Receivables Turnover5518.98866.2410.6766.2154.91
Payables Turnover1.250.313.231.811.73
Inventory Turnover3.020.925.982.242.53
Fixed Asset Turnover0.170.300.340.350.41
Asset Turnover0.150.260.280.300.31
Working Capital Turnover Ratio-0.24-0.63-1.30-1.38-1.72
Cash Conversion Cycle-170.85-795.91-17.74-33.00-60.49
Days of Sales Outstanding0.070.4234.225.516.65
Days of Inventory Outstanding121.02396.2661.00162.72144.20
Days of Payables Outstanding291.931192.59112.96201.24211.34
Operating Cycle121.09396.6895.22168.24150.85
Cash Flow Ratios
Operating Cash Flow Per Share-4.18-3.661.10-11.46-7.99
Free Cash Flow Per Share-5.65-5.31-3.27-16.50-18.89
Dividend Paid and CapEx Coverage Ratio-2.84-2.210.25-2.27-0.73
Capital Expenditure Coverage Ratio-2.84-2.210.25-2.27-0.73
Operating Cash Flow Coverage Ratio-0.04-0.040.01-0.13-0.09
Operating Cash Flow to Sales Ratio-0.38-0.180.05-0.47-0.29
Free Cash Flow Yield-14.20%-7.85%-5.07%-29.21%-13.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-5.06-5.41-7.05-4.93-6.93
Price-to-Sales (P/S) Ratio3.613.372.762.345.17
Price-to-Book (P/B) Ratio-0.53-1.00-1.17-1.22-4.11
Price-to-Free Cash Flow (P/FCF) Ratio-7.04-12.74-19.73-3.42-7.57
Price-to-Operating Cash Flow Ratio-9.52-18.4958.80-4.93-17.91
Price-to-Earnings Growth (PEG) Ratio0.14-0.150.350.11-0.16
Enterprise Value Multiple-90.67-24.99-45.64-20.11-15.12
Enterprise Value3.10B3.58B3.78B3.05B4.96B
EV to EBITDA-90.67-24.99-45.64-20.11-15.12
EV to Sales13.088.267.495.858.32
EV to Free Cash Flow-25.49-31.25-53.56-8.57-12.19
EV to Operating Cash Flow-34.47-45.36159.67-12.34-28.84
Tangible Book Value Per Share-75.58-68.91-56.45-47.38-36.16
Shareholders’ Equity Per Share-75.45-67.84-55.29-46.13-34.83
Tax and Other Ratios
Effective Tax Rate0.00-0.000.000.000.00
Revenue Per Share11.0020.0923.3924.1827.69
Net Income Per Share-7.85-12.50-9.15-11.45-20.65
Tax Burden1.001.001.001.001.00
Interest Burden1.721.281.311.141.14
Research & Development to Revenue0.000.040.000.000.03
SG&A to Revenue0.780.380.010.020.02
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.530.29-0.121.000.39

Currency in INR